Clinical Trials Browser

Recruiting × Endometrial Neoplasms × Drug Therapy × Clear all

NCT07022483 2026-02-04

Study of Trastuzumab Deruxtecan Versus Standard of Care Chemotherapy for HER2-Expressing (IHC 3+/2+) Endometrial Cancer

Phase 3 Recruiting

Neoplasms, Endometrial Neoplasms

NCT06877572 2025-10-27

ECS Weight

Endometrial Neoplasms

NCT05857631 2025-04-15

PARCERII

Phase NA Recruiting

Uterine Cervical Neoplasms, Endometrial Neoplasms

NCT05255653 2024-11-29

RAINBO

Phase 2/3 Recruiting

Endometrial Neoplasms